Light Mode
$1.64 ↓ -0.09 (-5.20%) Trading Down from the previous close of $1.73, and at the day’s high of $1.64
+0.01 (+0.58%) / 6M
Momentum, market sentiment, and recent alerts
BIVI reads not so good: price sits above both the 20- and 200-day averages, the 12-month move is +12.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
BioVie, Inc. is a biopharmaceutical company, which engages in discovery, development, and marketing drug therapies for neurological and neurodegenerative disorders, and liver disease. The company was founded on April 10, 2013 and is headquartered in Carson City, NV.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.